YourEra
NAD+
Writes an unusually clear compounding disclosure, labels three of its four prescription lines as compounded, and leaves NAD⁺ off that list.
- Best for
- Readers who will notice which product the disclosure skips
- From
- $170mo
Independent · NAD⁺ only
Independent reviews of NAD⁺ injections, IV therapy, nasal sprays and supplements — scored on evidence, price transparency, and what you actually get.
Or see exactly how we score a provider →
Scores are computed from a published rubric and never move with who pays us. The option we rate best on evidence is one we earn nothing from — and we say so on the page.
Subcutaneous NAD⁺ from telehealth prescribers — what a course actually costs, who ships it, and what the dosing evidence supports.
Explore →ivThe most expensive way to raise NAD⁺ and the one with the least outcome data. We price it honestly and say so.
Explore →oralNR and NMN reliably raise blood NAD⁺ in randomized trials and cost a fraction of a drip. The evidence ranking is the inverse of the price ranking.
Explore →We read the pricing page of every NAD⁺ seller we cover. On most of them the number in the largest type is not the number that repeats — and the gap has twelve recognizable shapes.
SafetyTwo sections of one federal law, quoted at you as if they were quality grades. One is a real difference in who inspects and to what standard — and neither makes a compounded drug FDA-approved.
FormatsThe syringe measures volume, not drug. Two steps converts the number in your instructions into the number you actually want — and shows why the same 20 units can be 20 mg or 40 mg.
Scores are computed from a published rubric — evidence, price transparency, value, ordering experience, clinical support. No provider carries a score we typed in by hand.
The scoring function does not read commercial status. Partners are shown first and labeled as such; that is display order, and it never touches the number.
Every price on this site was read off the provider's own page, not a program description. The two disagree more often than you would expect.
We rank providers on evidence and transparency. Commercial relationships set the order of partners — never the verdict.
Disclosure: NAD Picks is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
NAD+
Writes an unusually clear compounding disclosure, labels three of its four prescription lines as compounded, and leaves NAD⁺ off that list.
NAD+
Sells a three-month protocol at a monthly-looking price, with the page and the site FAQ quoting different figures for what that protocol costs.
NAD+
States a monthly milligram total, sells a genuine single month rather than only prepaid terms, and calls its own NAD⁺ investigational and not FDA-approved on the product page itself.
NAD+
Prints the milligrams beside the price on both its plans, which is rare here — and the arithmetic that makes possible shows the cheaper plan costing about 60% more per milligram than the larger one.
NAD+
States both the vial size and the second-month price on the same line — 500 mg, $119 to start and $186 after — which is more than most sellers disclose about either.
NAD+
Prices the injection and the nasal spray identically at $129, so the format is a preference rather than a cost decision.